Literature DB >> 8507389

Effects of D1 and D2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats.

W Dyr1, W J McBride, L Lumeng, T K Li, J M Murphy.   

Abstract

Dopamine receptor agonists and antagonists were tested for effects on alcohol drinking in female HAD rats (n = 10) given limited access (4 h/day) to a 10% (v/v) ethanol solution. Food and water were available ad libitum. Subcutaneous drug injections were given 30-60 min before the ethanol access periods. The D2 agonist quinpirole (0.04-2.0 mg/kg) caused a dose-dependent decrease in alcohol drinking throughout the 4-h period. Spiperone, a D2 antagonist, had no effect during the initial part of the session, but by the fourth hour, the 10 micrograms/kg dose tended to increase alcohol intake and the 30 micrograms/kg dose reduced intake. The D1 antagonist SCH-23390 (3-30 micrograms/kg) dose-dependently decreased ethanol drinking during the first hour of access. The D1 agonist SKF-38393 (2-6 mg/kg) also decreased alcohol intake, but it was less effective than SCH-23390. The findings implicate both D1 and D2 receptors in the reinforcing effects of alcohol drinking by the HAD line of rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507389     DOI: 10.1016/0741-8329(93)90037-o

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  28 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 2.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

3.  Motivational effects of ethanol in DARPP-32 knock-out mice.

Authors:  F O Risinger; P A Freeman; P Greengard; A A Fienberg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

4.  Adenosinergic regulation of binge-like ethanol drinking and associated locomotor effects in male C57BL/6J mice.

Authors:  Brandon M Fritz; Stephen L Boehm
Journal:  Pharmacol Biochem Behav       Date:  2015-05-29       Impact factor: 3.533

5.  Distinct Synaptic Strengthening of the Striatal Direct and Indirect Pathways Drives Alcohol Consumption.

Authors:  Yifeng Cheng; Cathy C Y Huang; Tengfei Ma; Xiaoyan Wei; Xuehua Wang; Jiayi Lu; Jun Wang
Journal:  Biol Psychiatry       Date:  2016-05-27       Impact factor: 13.382

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 7.  Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.

Authors:  Hitoshi Morikawa; Richard A Morrisett
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

8.  Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans rats.

Authors:  James M Doherty; Rueben A Gonzales
Journal:  Alcohol       Date:  2015-05-30       Impact factor: 2.405

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

10.  Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.

Authors:  Erkki Tupala; Håkan Hall; Kim Bergström; Tuija Mantere; Pirkko Räsänen; Terttu Särkioja; Jari Tiihonen
Journal:  Hum Brain Mapp       Date:  2003-10       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.